Use of chronic medications among a large, commercially-insured US population

被引:13
|
作者
Roe, CM
McNamara, AM
Motheral, BR
机构
[1] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[2] Express Scripts Inc, Womens Hlth, Maryland Hts, MO 63043 USA
[3] Express Scripts Inc, Outcomes Res, Maryland Hts, MO USA
关键词
chronic medication use; gender differences; sex differences; pharmacy claim database;
D O I
10.1002/pds.700
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To examine use of chronic therapies by females and males of all ages. Methods Participants were 1295 948 members of a large US pharmacy benefit manager. The use of chronic medications by males and females during 1999 was examined overall and within 16 commonly-used chronic drug groups. Dependent variables were use of a drug group, number of drug groups used, number of prescriptions filled and sum of costs, both within each drug group and overall, Combination therapy was defined as using at least two of the 16 chronic therapy groups during 1999. Results Females were more likely than males to use chronic medications during the study year (36.5 vs. 22.4%, p < 0.001). Generally, the likelihood of using a chronic medication increased with age for both sexes. Commonly-used chronic medications accounted for 54 and 50% of prescriptions for females and males respectively, and for 53% of total drug costs for both sexes. There were few meaningful sex differences in the likelihood of using particular drug groups. Of those who took chronic drugs 14% used combination chronic therapy. Conclusions This study provides demographic information regarding treatment of chronic conditions that can be used to aid policy decisions and to provide an impetus for future research. Copyright (C) 2002 John Wiley & Sons, Ltd.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 50 条
  • [21] CLAVICLE FRACTURE: TREATMENT, COMPLICATIONS, AND COST IN THE COMMERCIALLY-INSURED POPULATION
    Vanderkarr, M.
    Chitnis, A. S.
    Nandwani, P.
    Putnam, M.
    Holy, C. E.
    VALUE IN HEALTH, 2018, 21 : S268 - S268
  • [22] Economic burden of sarcoidosis in a commercially-insured population in the United States
    Rice, J. Bradford
    White, Alan
    Lopez, Andrea
    Conway, Alexandra
    Wagh, Aneesha
    Nelson, Winnie W.
    Philbin, Michael
    Wan, George J.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1048 - 1055
  • [23] PATELLA FRACTURE: COST, COMPLICATIONS AND TREATMENTS IN THE COMMERCIALLY-INSURED POPULATION
    Vanderkarr, M.
    Chitnis, A. S.
    Sparks, C.
    Holy, C. E.
    VALUE IN HEALTH, 2018, 21 : S175 - S176
  • [24] RATE OF HOSPITALIZATIONS AMONG PATIENTS WITH SYSTOLIC HEART FAILURE IN A COMMERCIALLY-INSURED UNITED STATES POPULATION
    Song, X.
    Wilson, K.
    Zhang, K.
    Lei, L.
    Monsalvo, M. L.
    Kim, J.
    Cong, Z.
    VALUE IN HEALTH, 2014, 17 (03) : A118 - A119
  • [25] ANALYSIS OF DULOXETINE UTILIZATION AMONG COMMERCIALLY-INSURED FIBROMYALGIA PATIENTS
    Chen, S. Y.
    Wu, N.
    Boulanger, L.
    Rao, P.
    Peng, X.
    Zhao, Y.
    VALUE IN HEALTH, 2010, 13 (03) : A143 - A143
  • [26] PREVALENCE OF HEPATIC OUTCOMES AMONG COMMERCIALLY-INSURED PATIENTS DIAGNOSED WITH CHRONIC HEPATITIS C VIRUS
    Scaife, J.
    Kuti, E.
    Acampa, L.
    Million, R.
    Miyasato, G.
    Wang, Z.
    Sander, S.
    Sanchez, H.
    Kokkotos, F. K.
    VALUE IN HEALTH, 2013, 16 (03) : A82 - A82
  • [27] Epidemiology and Treatment of Chronic Kidney Disease among Commercially-Insured Patients in the U.S
    Kauf, Teresa
    Wang, Weiying
    Dillon, Allison
    Singh, Inderjit
    Odegard, John T.
    Ringemann, Christian
    Haldrup, Steffen
    DIABETES, 2020, 69
  • [28] Prescription drug cost-sharing among commercially-insured children and adults with chronic illness
    Gibson, T. B.
    VALUE IN HEALTH, 2007, 10 (03) : A22 - A23
  • [29] Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States
    Zhou, Zhou
    Zhou, Zheng-Yi
    Kelkar, Sneha S.
    Sikirica, Vanja
    Xie, Jipan
    Grebla, Regina
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (04) : 585 - 592
  • [30] Comorbidity clusters in hidradenitis suppurativa in a large commercially insured population in the US
    Hua, V. J.
    Cho, H.
    Li, S.
    Sarin, K. Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S46 - S46